Nanosuspensions: Ideal approach for the drug delivery of poorly water soluble drugs

Der Pharmacia Lettre

Volumn 3, Issue 2, 2011, Pages 203-213

  Venkatesh, T ^a   Reddy, Avinash Kumar ^a   Uma Maheswari, J ^a   Deena Dalith, M ^a   Ashok Kumar, C K ^a  

^a Sree Vidyanikethan Engineering College   (India)

Author keywords

Homogenization.; Improving bioavailability; Nanosuspensions; Pooly water soluble drugs; Solubility enhancement

Indexed keywords

APHIDICOLIN; ASCORBYL PALMITATE; BUDESONIDE; BUSULFAN; CILOSTAZOL; CLOFAZIMINE; COSURFACTANT; DANAZOL; DEXAMETHASONE; DIHYDROARTEMISININ; DRUG ADDITIVE; FENOFIBRATE; FLUTICASONE; HYDROCORTISONE; INSULIN; LIPID; LOVIRIDE; MEGESTROL ACETATE; NANOCARRIER; NANOPARTICLE; NAPROXEN; ORGANIC SOLVENT; ORIDONIN; PACLITAXEL; PALIPERIDONE; PREDNISOLONE; PROBUCOL; SPIRONOLACTONE; STABILIZING AGENT;

ARTICLE; BIOCHEMISTRY; CRYSTAL STRUCTURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG RESEARCH; DRUG SOLUBILITY; DRUG SYNTHESIS; DRUG TARGETING; GRINDING; IN VIVO STUDY; MICROEMULSION; MUCOADHESION; NANOPHARMACEUTICS; NANOTECHNOLOGY; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRECIPITATION; SUPERCRITICAL FLUID; SUSPENSION; X RAY DIFFRACTION; ZETA POTENTIAL;

EID: 79955709641     PISSN: None     EISSN: 09755071     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. R.H. Müller, C. Jacobs, O. Kayer Nanosuspensions for the formulation of poorly soluble drugs in: F. Nielloud, G. Marti-Mestres (Eds), Pharmaceutical emulsion and suspension, Marcel Dekker, New York, 2000.
2. J.E. Kipp, J.C.T. Wong, M.J. Doty, C.L. Rebbeck. US Patent 6,607,784 (2003).
3. X. Zhang, Q. Xia, N. Gu. Drug Dev Ind Pharm, 2006, 32, 857-63.
4. P. Kocbek, S. Baumgartner, J. Kristl. Int J Pharm, 2006, 312, 179-86.
5. J. Möschwitzer, G. Achleitner, H. Pomper, R.H. Müller. Eur J Pharm Biopharm 2004, 58, 615-9.
6. V.B. Patravale, A.A. Date, R.M. Kulkarni. J Pharm Pharmacol, 2004, 56, 827-40.
7. G.G. Liversidge, K.C. Cundy, J.F. Bishop, D.A. Czekai. US Patent 5,145,684 (1992).
8. K. Itoh, A. Pongpeerapat, Y. Tozuka, T. Oguchi, K. Yamamoto. Chem Pharm Bull, 2003, 51, 171-4.
9. Wongmekiat, Y. Tozuka, T. Oguchi, K.Yamamoto. Pharm Res 2002, 19, 1867-72.
10. H.M. Abdou Dissolution, in: A.R. Gennaro, J.B. Schwartz (Eds), Remington's Pharm. Sci., Mack Publishing Company, Easton, PA, 1990.
11. C. Nyström Dissolution properties of soluble drugs: Theoretical background and possibilities to improve the dissolution behaviour in: R.H. Müller, S. Benita, B. Böhm (Eds),Emulsions and Nanosuspensions for the Formulation of Poorly Soluble Drugs, Medpharm, Stuttgart, 1998, 143-148.
12. M.N. Mosharraf. Int J Pharm, 1995, 122, 35-47.
13. R.H. Müller, C. Jacobs. Pharm Res, 2002, 19,189-194.
14. Y.C. Liang, J.G.P. Binner. Ceram Int, 2008, 34, 293-297.
15. D. Duchêne, G. Ponchel. Eur J Pharm Biopharm, 1997, 44, 15-23.
16. C.J. Van Oss, D.R. Absolom, H.W. Neumann. Ann NY Acad Sci, 1984, 416, 332-350.
17. K.H. Wallis, R.H. Müller. Pharm Ind, 1993, 55, 1124-1128.
18. C.M. Keck, R.H. Müller. Eur J Pharm Biopharm, 2006, 62, 3-16.
19. F. Kesisoglou, S. Panmai, Y. Wu. Adv Drug Deliv Rev, 2007, 59, 631-44.
20. Xiaohui Pu, Jin Sun, Mo Li, Zhonggui He. Current Nanoscience, 2009, 5, 417-427.